MITOSAN PLUS 40MG+12.5MG Tablet contains Mitotane 40 mg and Hydrocortisone 12.5 mg. It is a combination medicine used mainly in the management of adrenocortical carcinoma (ACC), where mitotane reduces adrenal cortical tumor activity and hydrocortisone provides corticosteroid replacement due to reduced adrenal hormone production.
Uses:
-
Treatment of adrenocortical carcinoma (cancer of the adrenal cortex).
-
Helps control excess adrenal hormone production caused by adrenal tumors.
-
Provides cortisol replacement therapy during mitotane treatment when adrenal function is reduced.
-
Used under the supervision of an oncologist/endocrinologist.
Dose:
-
Adults: Dose is individualized according to disease condition, mitotane blood levels, adrenal hormone status, and response to treatment.
-
Take the medicine exactly as prescribed by a healthcare professional.
-
Dose and duration depend on the patient's condition and monitoring results.
-
Regular monitoring of hormone levels, liver function, and overall health may be required.
-
Do not stop or change the dose without medical advice.